Usana Health Sciences Inc (USNA)
EBITDA Growth
-56.83%
TTM · Period ending:
USNA EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-56.83%period ending
Latest reported-56.83%period ending
USNA TTM EBITDA YoY % (156.14% → -56.83%)
Year-over-year change
High-resolution chart · PNG
USNA ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -58.1726% | |
| -64.6397% | |
| -53.5949% | |
| -36.4841% | |
| -23.4251% | |
| -7.9488% | |
| -0.0968% | |
| 3.2514% | |
| 17.2134% | |
| 33.4931% | |
| 45.3125% | |
| 70.4762% | |
| 72.6316% | |
| 56.5217% | |
| 45.4545% | |
| 25% | |
| 37.6812% | |
| -11.5385% | |
| -39.726% | |
| -44.7368% | |
| -57.1429% | |
| -11.8644% | |
| 156.1404% |